In this file
  1. Start with the published offer
  2. Build a complete payment picture
  3. Check the commitment behind the saving
  4. Make the clinical comparison match
  5. A practical quote request
  6. Read the connected files
  7. Source notes

Before budgeting for Hims, identify the event that produces a charge: joining a care program, buying a prescription, renewing a package, or booking a consultation. Those events can happen on different dates.

The main pricing detail in the documents is: Current branded and compounded pathways should be checked against the dated policy shift. Below, we distinguish the published figures from calculations and items that still require a personal quote.

Start with the published offer

The current documents distinguish Weight Loss Membership from a Medication Plan. We did not establish one current combined price for every product and pathway. Quotes copied from an older compounded-semaglutide campaign may not describe enrollment today.

Hims sits within Hims & Hers and separates its platform from the medical and pharmacy services described in its terms. The March 2026 company announcement changed its weight-loss strategy toward approved products, while describing limited compounding based on clinical need.

Build a complete payment picture

Ask Hims for a dated summary with four lines: the amount due at enrollment, any separate medicine charge, the amount due at the next refill, and the total obligation under the chosen term. If no prescription has been issued, ask which parts can change after clinical assessment.

Add required care and testing to medication before comparing providers. A price per dose, a price per four weeks, and a calendar-month subscription cannot be compared simply by placing their headline numbers together. Start with the same treatment period and then compare the money needed upfront.

Check the commitment behind the saving

The August 31 terms say the first membership month is non-refundable and shipped medication is not refundable. Other medication cancellation and refund circumstances have their own timing rules. Read the membership clause and medication clause independently, then ask which applies to the pending charge.

A prepaid discount exchanges flexibility for a lower stated average. Financing may spread payments while leaving the full obligation in place. Ask what happens if treatment stops, changes, or cannot be prescribed, and whether that affects the medicine payment, membership, or both.

Make the clinical comparison match

The strategic announcement is neither proof that compounding disappeared completely nor a promise that it is available on request. The treating professional should name the actual medicine and explain the medical reason for any proposed compounded preparation.

Do not budget for a different route or a starter prescription merely because it is cheaper. The clinician determines the treatment; the financial comparison should then describe that actual product and the care that accompanies it.

A practical quote request

Is this quote for membership, medication, or both, and what product would a current clinician actually consider?

The published telephone number for Hims is (800) 368-0038.

For questions about an existing bill, use the Hims contact file and keep the charge date, statement description, and receipt available. Use secure channels for any treatment record.

Read the connected files

The Hims provider file connects the cost details, support routes, and cancellation questions so that the same plan can be checked from more than one angle.

To compare several offers on the same basis, use the GLP-1 price worksheet. It separates a low initial payment from an affordable ongoing plan.

Source notes

Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.

  1. Hims & Hers: March 9, 2026 weight-loss strategy announcementProvider-published information · Checked September 22, 2026
  2. Hims: terms updated August 31, 2026Provider-published information · Checked September 22, 2026
  3. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 22, 2026
This article is educational research, not personal medical advice. A treating clinician should assess your circumstances. Research limits · Commercial disclosure · Contact information